G261-1027 Screening compound: methyl 4-(6-ethyl-2,2-dimethyl-4-oxo-2,3,4,9-tetrahydro-1H-carbazole-7-sulfonamido)benzoate

G261-1027 Screening compound: methyl 4-(6-ethyl-2,2-dimethyl-4-oxo-2,3,4,9-tetrahydro-1H-carbazole-7-sulfonamido)benzoate
G261-1027 Screening compound: methyl 4-(6-ethyl-2,2-dimethyl-4-oxo-2,3,4,9-tetrahydro-1H-carbazole-7-sulfonamido)benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound G261-1027
methyl 4-(6-ethyl-2,2-dimethyl-4-oxo-2,3,4,9-tetrahydro-1H-carbazole-7-sulfonamido)benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G261-1027

Molecular Formula

C24H26N2O5S (C24 H26 N2 O5 S)

Compound Name

methyl 4-(6-ethyl-2,2-dimethyl-4-oxo-2,3,4,9-tetrahydro-1H-carbazole-7-sulfonamido)benzoate

IUPAC name

methyl 4-(6-ethyl-22-dimethyl-4-oxo-2349-tetrahydro-1H-carbazole-7-sulfonamido)benzoate

SMILES

CCc(cc1c(C(CC(C)(C)C2)=O)c2[nH]c1c1)c1S(Nc(cc1)ccc1C(OC)=O)(=O)=O

InChI

InChI=1S/C24H26N2O5S/c1-5-14-10-17-18(25-19-12-24(2,3)13-20(27)22(17)19)11-21(14)32(29,30)26-16-8-6-15(7-9-16)23(28)31-4/h6-11,25-26H,5,12-13H2,1-4H3

InChI Key

ZCDGATHBQBJRNX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14990597

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

454.55

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.415

Distribution Coefficient, logD

2.863

Water Solubility, LogSw

-4.51

Polar Surface Area

86.080

Acid Dissociation Constant (pKa)

5.86

Base Dissociation Constant (pKb)

-3.38

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

G261-1027 in Drug Discovery

Included in Screening Libraries

SH2 Library (10483 compounds)

Neuropeptide S Library (2850 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Endocrine
  • Digestive system
  • Nervous system
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with G261-1027 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G261-1027?
Check Price and Availability of G261-1027, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G261-1027 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G261-1027
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G261-1027
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G261-1027 available by request